<DOC>
	<DOCNO>NCT00167856</DOCNO>
	<brief_summary>The purpose study evaluate pain-relieving effect venlafaxine hydrochloride ( Effexor ) chronic neuropathic ( burn , shock-like , electric ) pain spinal cord injury ( SCI ) . Although number medication use treat SCI pain , drug consistently helpful , , therefore , many people SCI continue difficult chronic pain . Venlafaxine new anti-depressant drug test use SCI neuropathic pain , helpful type neuropathic pain .</brief_summary>
	<brief_title>Effects Venlafaxine Chronic Neuropathic Pain Following Spinal Cord Injury</brief_title>
	<detailed_description>Persistent pain one common reason impaired quality life follow spinal cord injury ( SCI ) . Although numerous intervention often use manage neuropathic pain follow SCI , people receive inadequate relief continue suffer many year original injury . The long-term goal pain research improve management chronic neuropathic pain follow SCI . This study examine effect Venlafaxine hydrochloride ( VH ) treatment chronic neuropathic pain associate SCI . VH second-generation , structurally novel antidepressant medication mild side-effect profile compare old tricyclic antidepressant ( e.g . imipramine amitriptyline ) . Previous clinical trial suggest approximately 60-70 % people heterogeneous neuropathic pain report least moderate reduction pain old antidepressant . However , report side-effects numerous , trial conduct neuropathic pain due SCI . The current study two-period , 24-week crossover , randomize , placebo-controlled trial . A sample 60 person chronic neuropathic pain SCI randomly assign either two treatment group ( n=30 group ) , double-blind fashion . One group receive VH first placebo , whereas second group start placebo follow VH . There weekly contact research staff study participant assess pain relief medication side effect ( presence severity ) . Several measure pain intensity , psychosocial well-being , quality life , sensory function take throughout study examine effect VH neuropathic pain . We expect VH help relieve neuropathic pain person SCI , decrease pain intensity correlate reduce psychosocial impact , improve mood , increased participation daily activity , increase life satisfaction .</detailed_description>
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Spinal Cord Injuries</mesh_term>
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Venlafaxine Hydrochloride</mesh_term>
	<criteria>participant must able swallow pill fluent English incomplete complete spinal cord injury presence least moderately severe neuropathic pain level injury spinal cord injury least 2 year prior enter study pain least 6 month prior enter study spinal cord injury level L1 participant anticonvulsant consider approval primary physician pregnant woman , contemplate pregnancy prior history use Venlafaxine hydrochloride ( Effexor ) current use MAOI medication person recent ( past year ) history alcohol drug abuse person history renal disease , heart disease uncontrolled hypertension , liver disease hepatic cirrhosis , active major medical psychiatric illness person significant posttraumatic encephalopathy head trauma sustain SCI person tardive dyskinesia narrow angle glaucoma</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>Burning pain</keyword>
	<keyword>Clinical trial</keyword>
	<keyword>Effexor</keyword>
	<keyword>Pain</keyword>
	<keyword>Spinal cord injury</keyword>
	<keyword>Venalafaxine</keyword>
	<keyword>Neuropathic Pain</keyword>
</DOC>